The Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorisation for Mounjaro, a new therapy, to treat type 2 diabetes in adults. This authorization comes after promising results from https://robertkbpx131395.mpeblog.com/72208489/latest-medication-approved-in-the-uk-for-type-2-diabetes